Center for Advanced Endoscopy, Research and Education Metrics @accordionTitleTag.Name>
Total Procedures |
952 |
Total Procedures FY23-24 |
767 |
DHI |
Benchmark |
|
Technical Success for procedures Failed outside ERCP = 12, Failed outside EUS = 11; Failed resections = 41 |
98.9% |
>90% |
Technical Failures Failed cannulation = 3; Failed resection = 4, Failed EUS-guided interventions = 3 |
1.05% |
- - |
Adverse Events post-ERCP pancreatitis = 7; post-resection bleeding = 4, post-resection bleeding = 4, perforation = 1 |
1.26% |
≤10% |
Referrals to Surgery/Others by CARE |
23 |
Inpatient Transfers to CARE |
189 |
Post-Procedure Admissions |
67 |
EPOCH (Chronic Pancreatitis Randomized Trial) 2 |
3 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
GOOSE (EUS vs. Surgery Gastrojejunostomy Randomized Trial) |
Complete |
Physician Journal Clubs |
1 |
Publications |
2 |
Total Procedures |
917 |
Total Procedures FY23-24 |
763 |
Technical Success for procedures Failed outside ERCP = 11, Failed outside EUS = 13; Failed resections = 38 |
98.7% |
Technical Failures Failed cannulation = 5; Failed resection = 4, Failed EUS-guided interventions = 3 |
1.3% |
Adverse Events post-ERCP pancreatitis = 7, post-resection bleeding = 4, post-resection bleeding = 4, post-necrosectomy bleeding/death = 1, perforation = 0 |
1.3% |
Referrals to Surgery/Others by CARE |
6 |
Inpatient Transfers to CARE |
181 |
Post-Procedure Admissions |
54 |
EPOCH (Chronic Pancreatitis Randomized Trial) 2 |
3 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
GOOSE (EUS vs. Surgery Gastrojejunostomy Randomized Trial) |
Complete |
Physician Journal Clubs |
1 |
Publications |
2 |
Total Procedures |
1042 |
Total Procedures FY23-24 |
784 |
Technical Success for procedures Failed outside ERCP = 14, Failed outside EUS = 17; Failed resections = 41 |
99.6% |
Technical Failures Failed cannulation = 3; Failed resection = 4, Failed EUS-guided interventions = 0 |
0.4% |
Adverse Events post-ERCP pancreatitis = 6, post-resection bleeding = 4, perforation = 0 |
0.95% |
Referrals to Surgery/Others by CARE |
7 |
Inpatient Transfers to CARE |
186 |
Post-Procedure Admissions |
59 |
EPOCH (Chronic Pancreatitis Randomized Trial) 2 |
2 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
GOOSE (EUS vs. Surgery Gastrojejunostomy Randomized Trial) |
Complete |
Physician Journal Clubs |
1 |
Publications |
2 |
Total Procedures |
938 |
Total Procedures FY23-24 |
722 |
Technical Success for procedures Failed outside ERCP = 14, Failed outside EUS = 12; Failed resections = 27 |
99.6% |
Technical Failures Failed cannulation = 1; Failed resection = 3, Failed EUS-guided interventions = 0 |
0.4% |
Adverse Events post-ERCP pancreatitis = 6, post-resection bleeding = 2, perforation = 0 |
0.84% |
Referrals to Surgery/Others by CARE |
7 |
Inpatient Transfers to CARE |
155 |
Post-Procedure Admissions |
40 |
AI EUG (Registry) |
Complete |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs Surgery Gastrojejunostomy Randomized Trial |
Complete |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
517 |
Inpatient Procedures (Inclusive of outside transfers) |
202 |
ERCP |
101 |
EUS (Diagnostic 150, Biopsies 136, Stents 3, CP interventions 18) |
307 |
Upper GI endoscopy (Diagnostic 144, Tissue Resection 67, Stents 0, RFA 17) |
240 |
Lower GI endoscopy (Diagnostic 163, Tissue Resection 101) |
264 |
Enteroscopy |
30 |
Third Space Endoscopy |
4 |
Total Procedures |
946 |
Technical Success for procedures Failed outside ERCP = 15, Failed outside EUS = 12; Failed resections = 22 |
99.3% |
Technical Failures Failed cannulation = 3; Failed resection = 3, Failed EUS- guided interventions = 1 |
0.7% |
Adverse Events post-ERCP pancreatitis = 3, post-resection bleeding = 3, perforation = 1 |
0.7% |
Referrals to Surgery/Others by CARE |
9 |
Inpatient Transfers to CARE |
153 |
Post-Procedure Admissions |
54 |
EPOCH (Chronic Pancreatitis Randomized Trial) |
0 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
0 |
GOOSE (EUS vs. Surgery Gastrojejunostomy Randomized Trial) |
COMPLETE |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
576 |
Inpatient Procedures (Inclusive of outside transfers) |
289 |
ERCP |
114 |
EUS (Diagnostic 154, Biopsies 171, Stents 19, CP interventions 16) |
360 |
Upper GI endoscopy (Diagnostic 141, Tissue Resection 67, Stents 0, RFA 16 ) |
224 |
Lower GI endoscopy (Diagnostic 166, Tissue Resection 116) |
282 |
Enteroscopy |
18 |
Third Space Endoscopy |
6 |
Total Procedures |
1004 |
Technical Success for procedures Failed outside ERCP = 19, Failed outside EUS = 14; Failed resections =31 |
99.4% |
Technical Failures Failed cannulation = 3; Failed resection = 4, Failed EUS- guided interventions = 2 |
0.89% |
Adverse Events post-ERCP pancreatitis = 7, post-resection bleeding = 3, perforation = 0 |
0.4% |
Referrals to Surgery/Others by CARE |
11 |
Inpatient Transfers to CARE |
137 |
Post-Procedure Admissions |
42 |
AI-EUS (Registry) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
1 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
475 |
Inpatient Procedures (Inclusive of outside transfers) |
202 |
ERCP |
100 |
EUS (Diagnostic 165, Biopsies 137, Stents 14, CP interventions 4) |
320 |
Upper GI endoscopy (Diagnostic 122, Tissue Resection 64, Stents 0, RFA 13 ) |
199 |
Lower GI endoscopy (Diagnostic 149, Tissue Resection 101) |
250 |
Enteroscopy |
24 |
Third Space Endoscopy |
9 |
Total Procedures |
902 |
Technical Success for procedures Failed outside ERCP = 21, Failed outside EUS = 16; Failed resections =41 |
99.2.% |
Technical Failures Failed cannulation = 2; Failed resection = 3, Failed EUS- guided interventions = 2 |
0.77% |
Adverse Events post-ERCP pancreatitis = 10, post-resection bleeding = 3, perforation = 1 |
1.55% |
Referrals to Surgery/Others by CARE |
14 |
Inpatient Transfers to CARE |
124 |
Post-Procedure Admissions |
60 |
AI-EUS (Registry) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
0 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
451 |
Inpatient Procedures (Inclusive of outside transfers) |
196 |
ERCP |
94 |
EUS (Diagnostic 134, Biopsies 111, Stents 12, CP interventions 4) |
261 |
Upper GI endoscopy (Diagnostic 120, Tissue Resection 69, Stents 1, RFA 9 ) |
199 |
Lower GI endoscopy (Diagnostic 157, Tissue Resection 101) |
258 |
Enteroscopy |
23 |
Third Space Endoscopy |
10 |
Total Procedures |
845 |
Technical Success for procedures Failed outside ERCP = 12, Failed outside EUS = 9; Failed resections = 41 |
98.8% |
Technical Failures Failed cannulation = 3; Failed resection = 5, Failed EUS- guided interventions = 2 |
1.2% |
Adverse Events post-ERCP pancreatitis = 6, post-resection bleeding = 3, perforation = 1 |
1.2% |
Referrals to Surgery/Others by CARE |
11 |
Inpatient Transfers to CARE |
126 |
Post-Procedure Admissions |
54 |
AI-EUS (Registry) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
3 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
1 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
517 |
Inpatient Procedures (Inclusive of outside transfers) |
111 |
ERCP |
111 |
EUS (Diagnostic 141, Biopsies 129, Stents 7, CP interventions 20) |
297 |
Upper GI endoscopy (Diagnostic 109, Tissue Resection 65, Stents 0, RFA 11 ) |
185 |
Lower GI endoscopy (Diagnostic 138, Tissue Resection 91) |
229 |
Enteroscopy |
15 |
Third Space Endoscopy |
6 |
Total Procedures |
843 |
Technical Success for procedures Failed outside ERCP = 19, Failed outside EUS = 11; Failed resections =61 |
98.7% |
Technical Failures Failed cannulation = 4; Failed resection = 5, Failed EUS- guided interventions = 2 |
1.3% |
Adverse Events post-ERCP pancreatitis = 5, post-resection bleeding = 4, post-EUS-intervention bleeding = 1, perforation = 1 |
1.3% |
Referrals to Surgery/Others by CARE |
9 |
Inpatient Transfers to CARE |
146 |
Post-Procedure Admissions |
40 |
AI-EUS (Registry) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
2 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
442 |
Inpatient Procedures (Inclusive of outside transfers) |
216 |
ERCP |
107 |
EUS (Diagnostic 188, Biopsies 142, Stents 16, CP interventions 11) |
393 |
Upper GI endoscopy (Diagnostic 99, Tissue Resection 52, Stents 1, RFA 10 ) |
197 |
Lower GI endoscopy (Diagnostic 118, Tissue Resection 106) |
245 |
Enteroscopy |
16 |
Third Space Endoscopy |
13 |
Total Procedures |
921 |
Technical Success for procedures Failed outside ERCP = 20, Failed outside EUS = 17; Failed resections =45 |
99.02% |
Technical Failures Failed cannulation = 2; Failed resection = 2, Failed EUS- guided interventions = 1 |
0.98% |
Adverse Events post-ERCP pancreatitis = 4, post-resection bleeding = 3, post-EUS-intervention bleeding = 1, perforation = 1 |
0.98% |
Referrals to Surgery/Others by CARE |
8 |
Inpatient Transfers to CARE |
163 |
Post-Procedure Admissions |
39 |
AI-EUS (Registry) |
56 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
1 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
447 |
Inpatient Procedures (Inclusive of outside transfers) |
187 |
ERCP |
121 |
EUS (Diagnostic 188, Biopsies 142, Stents 16, CP interventions 11) |
357 |
Upper GI endoscopy (Diagnostic 99, Tissue Resection 52, Stents 1, RFA 10 ) |
187 |
Lower GI endoscopy (Diagnostic 118, Tissue Resection 106) |
187 |
Enteroscopy |
32 |
Third Space Endoscopy |
11 |
Total Procedures |
888 |
Technical Success for procedures Failed outside ERCP = 20, Failed outside EUS = 17; Failed resections =38 |
98.5% |
Technical Failures Failed cannulation = 4; Failed resection = 8, Failed EUS- guided interventions = 1 |
1.5% |
Adverse Events post-ERCP pancreatitis = 4, post-resection bleeding = 4, post-EUS bleeding = 1 |
1.01% |
Referrals to Surgery/Others by CARE |
10 |
Inpatient Transfers to CARE |
188 |
Post-Procedure Admissions |
42 |
AI-EUS (Registry) |
46 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
0 |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
471 |
Inpatient Procedures (Inclusive of outside transfers) |
211 |
ERCP |
111 |
EUS (Diagnostic 188, Biopsies 142, Stents 16, CP interventions 11) |
357 |
Upper GI endoscopy (Diagnostic 99, Tissue Resection 52, Stents 1, RFA 10 ) |
162 |
Lower GI endoscopy (Diagnostic 118, Tissue Resection 106) |
224 |
Enteroscopy |
19 |
Third Space Endoscopy |
12 |
Total Procedures |
885 |
Technical Success for procedures Failed outside ERCP = 21, Failed outside EUS = 18; Failed resections =39 |
98.09% |
Technical Failures Failed cannulation = 3; Failed resection = 4, Failed EUS- guided interventions = 2 |
1.01% |
Adverse Events post-ERCP pancreatitis = 5, post-resection bleeding = 3, post-EUS perforation = 1 |
1.01% |
Referrals to Surgery/Others by CARE |
11 |
Inpatient Transfers to CARE |
142 |
Post-Procedure Admissions |
58 |
AI-EUS (Registry) |
87 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
1 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
416 |
Inpatient Procedures (Inclusive of outside transfers) |
186 |
ERCP |
101 |
EUS (Diagnostic 188, Biopsies 142, Stents 16, CP interventions 11) |
310 |
Upper GI endoscopy (Diagnostic 99, Tissue Resection 52, Stents 1, RFA 10 ) |
132 |
Lower GI endoscopy (Diagnostic 118, Tissue Resection 106) |
192 |
Enteroscopy |
20 |
Third Space Endoscopy |
12 |
Total Procedures |
767 |
Technical Success for procedures Failed outside ERCP = 17, Failed outside EUS = 11; Failed resections =31 |
99.4% |
Technical Failures Failed cannulation = 2; Failed resection = 3, Failed EUS- guided interventions = 0 |
0.6% |
Adverse Events post-ERCP pancreatitis = 8, post-resection bleeding = 5, post-EUS bile leak = 0, post-EUS-FNA bleeding = 0 |
1.7% |
Referrals to Surgery/Others by CARE |
10 |
Inpatient Transfers to CARE |
147 |
Post-Procedure Admissions |
48 |
AI-EUS (Registry) |
90 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
3 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
0 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
416 |
Inpatient Procedures (Inclusive of outside transfers) |
157 |
ERCP |
103 |
EUS (Diagnostic 168, Biopsies 122, Stents 6, CP interventions 16) |
312 |
Upper GI endoscopy (Diagnostic 76, Tissue Resection 44, Stents 0, RFA 7 ) |
127 |
Lower GI endoscopy (Diagnostic 99, Tissue Resection 90, Stents 0) |
189 |
Enteroscopy |
28 |
Third Space Endoscopy |
4 |
Total Procedures |
763 |
Technical Success for procedures Failed outside ERCP = 11, Failed outside EUS = 13; Failed resections = 25 |
99.5% |
Technical Failures Failed cannulation = 1; Failed resection = 3, Failed EUS- guided interventions = 0 |
0.5% |
Adverse Events post-ERCP pancreatitis = 4, post-resection bleeding = 2, post-EUS bile leak = 1, post-EUS-FNA bleeding = 0 |
0.9% |
Referrals to Surgery/Others by CARE |
7 |
Inpatient Transfers to CARE |
143 |
Post-Procedure Admissions |
25 |
AI-EUS (Registry) |
91 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
1 |
Physician Journal Clubs |
1 |
Publications |
3 |
Outpatient Referrals |
456 |
Inpatient Procedures (Inclusive of outside transfers) |
168 |
ERCP |
96 |
EUS (Diagnostic 182, Biopsies 124, Stents 7, CP interventions 11) |
324 |
Upper GI endoscopy (Diagnostic 87, Tissue Resection 45, Stents 0, RFA 7) |
139 |
Lower GI endoscopy (Diagnostic 101, Tissue Resection 81, Stents 1) |
183 |
Enteroscopy |
30 |
Third Space Endoscopy |
12 |
Total Procedures |
784 |
Technical Success for procedures Failed outside ERCP = 14 , Failed outside EUS = 6 ; Failed resections = 22 |
99.2% |
Technical Failures Failed cannulation = 2; Failed resection =2, Failed EUS- guided interventions = 2 |
0.8% |
Adverse Events Post-ERCP pancreatitis = 3, Post-resection bleeding = 3, Post-EUS bile leak = 1, Post-EUS-FNA bleeding = 1 |
1.0% |
Referrals to Surgery/Others by CARE |
7 |
Inpatient Transfers to CARE |
148 |
Post-Procedure Admissions |
27 |
AI-EUS (Registry) |
14 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
0 |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
352 |
Inpatient Procedures (Inclusive of outside transfers) |
171 |
ERCP |
103 |
EUS (Diagnostic 181, Biopsies 84, Stents 4, CP interventions 10) |
279 |
Upper GI endoscopy (Diagnostic 77, Tissue Resection 31, Stents 0, RFA 10) |
118 |
Lower GI endoscopy (Diagnostic 122, Tissue Resection 73, Stents 1) |
196 |
Enteroscopy |
20 |
Third Space Endoscopy |
6 |
Total Procedures |
722 |
Technical Success for procedures Failed outside ERCP = 18, Failed outside EUS = 12, Failed resections = 9 |
99.5% |
Technical Failures = 4 Failed cannulation = 1, Failed resection = 3 |
0.5% |
Adverse Events Post-ERCP pancreatitis = 4; Post-resection bleeding = 2 |
0.8% |
Referrals to Surgery/Others by CARE |
7 |
Inpatient Transfers to CARE |
105 |
Post-Procedure Admissions |
31 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
PUBLISHED |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
0 |
Physician Journal Clubs |
1 |
Publications |
3 |
Outpatient Referrals |
347 |
Inpatient Procedures (Inclusive of outside transfers) |
138 |
ERCP |
93 |
EUS (Diagnostic 196, Biopsies 70, Stents 5, Celiac interventions 15) |
286 |
Upper GI endoscopy (Diagnostic 96, Tissue Resection 26, Stents 0, RFA 8) |
130 |
Lower GI endoscopy (Diagnostic 117, Tissue Resection 55, Stents 0) |
172 |
Enteroscopy |
19 |
Third Space Endoscopy |
9 |
Total Procedures |
709 |
Technical Success for procedures Failed outside ERCP = 11, Failed outside EUS = 8, Failed outside resections = 7 |
99.2% |
Technical Failures = 7 Failed cannulation = 2, Failed resection = 2, Failed EUS = 2 |
0.8% |
Adverse Events Post-ERCP pancreatitis =2, Death from PE =1, Infection = 1 |
0.5% |
Referrals to Surgery/Others by CARE |
8 |
Inpatient Transfers to CARE |
129 |
Post-Procedure Admissions |
36 |
GOOSE (Surgery vs. EUS for Gastro-jejunostomy Randomized Trial) |
1 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EPOCH (EUS vs. sham therapy for chronic pancreatitis) |
STARTED |
Physician Journal Clubs |
1 |
Publications |
4 |
Outpatient Referrals |
410 |
Inpatient Procedures (Inclusive of outside transfers) |
215 |
ERCP |
105 |
EUS (Diagnostic 177, Biopsies 121, Stents 12, CP interventions 27) |
337 |
Upper GI endoscopy (Diagnostic 91, Tissue Resection 42, Stents 0, RFA 6) |
139 |
Lower GI endoscopy (Diagnostic 136, Tissue Resection 71, Stents 1) |
208 |
Enteroscopy |
26 |
Third Space Endoscopy |
2 |
Total Procedures |
817 |
Technical Success for procedures =808 Failed outside ERCP = 11, Failed outside EUS = 6, Failed outside EMR = 9 |
99.1% |
Technical Failures = 7 Failed cannulation = 3, Failed EMR/ESD = 4 |
99.1% |
Adverse Events = 4 Post-ERCP Pancreatitis = 3, Post-procedure bleeding/sepsis = 3 |
0.5% |
Referrals to Surgery/Others by CARE |
10 |
Inpatient Transfers to CARE |
136 |
Post-Procedure Admissions |
31 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS – Gastric Outlet Obstruction Randomized Trial |
0 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
349 |
Inpatient Procedures (Inclusive of outside transfers) |
184 |
ERCP |
89 |
EUS (Diagnostic 142, Biopsies 82, Stents 10, CP interventions 10) |
244 |
Upper GI endoscopy (Diagnostic 90, Tissue Resection 22, Stents 0, RFA 9) |
121 |
Lower GI endoscopy (Diagnostic 127, Tissue Resection 61, Stents 1) |
189 |
Enteroscopy |
21 |
Third Space Endoscopy |
3 |
Total Procedures |
667 |
Technical Success for procedures = 657 Failed outside ERCP = 8, Failed outside EUS = 5, Failed outside EMR = 8 |
98.5% |
Technical Failures = 10 Failed cannulation = 4, Failed EMR/ESD = 4, Failed EUS-intervention = 2 |
1.5% |
Adverse Events = 8 Pancreatitis = 4, Post-procedure pain/bleeding = 4 |
1.2% |
Referrals to Surgery/Others by CARE |
8 |
Inpatient Transfers to CARE |
89 |
Post-Procedure Admissions |
24 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS - Pancreatic cancer molecular marker study |
COMPLETE |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
427 |
Inpatient Procedures (Inclusive of outside transfers) |
116 |
ERCP |
79 |
EUS (Diagnostic 140, Biopsies 99, Stents 14, CP interventions 18) |
264 |
Upper GI endoscopy (Diagnostic 82, Tissue Resection 30, Stents 0, RFA 18) |
141 |
Lower GI endoscopy (Diagnostic 133, Tissue Resection 79, Stents 1) |
213 |
Enteroscopy |
12 |
Third Space Endoscopy |
16 |
Total Procedures |
715 |
Technical Success for procedures Failed outside ERCP 21; Failed outside EUS = 9; Failed outside resections = 6 |
99.8% |
Technical Failures: 7, failed cannulation = 3; failed resection = 2; failed EUS intervention = 2 |
1.2% |
Adverse Events: post-ERCP pancreatitis =4; post-resection bleeding =2 |
1.2% |
Referrals to Surgery/Others by CARE |
13 |
Inpatient Transfers to CARE |
117 |
Post-Procedure Admissions |
28 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery Gastro-jejunostomy Randomized Trial |
1 |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
321 |
Inpatient Procedures (Inclusive of outside transfers) |
211 |
ERCP |
81 |
EUS (Diagnostic 140, Biopsies 99, Stents 14, CP interventions 18) |
255 |
Upper GI endoscopy (Diagnostic 82, Tissue Resection 30, Stents 0, RFA 18) |
185 |
Lower GI endoscopy (Diagnostic 133, Tissue Resection 79, Stents 1) |
100 |
Enteroscopy |
10 |
Third Space Endoscopy |
6 |
Total Procedures |
637 |
Technical Success for procedures Failed outside ERCP 21; Failed outside EUS = 9; Failed outside resections = 6 |
99.4% |
Technical Failures: 7, failed cannulation = 3; failed resection = 2; failed EUS intervention = 2 |
0.8% |
Adverse Events: post-ERCP pancreatitis =4; post-resection bleeding =2 |
0.6% |
Referrals to Surgery/Others by CARE |
12 |
Inpatient Transfers to CARE |
137 |
Post-Procedure Admissions |
27 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery Gastro-jejunostomy Randomized Trial |
2 |
Physician Journal Clubs |
1 |
Publications |
0 |
Outpatient Referrals |
346 |
Inpatient Procedures (Inclusive of outside transfers) |
201 |
ERCP |
90 |
EUS (Diagnostic 140, Biopsies 99, Stents 14, CP interventions 18) |
276 |
Upper GI endoscopy (Diagnostic 82, Tissue Resection 30, Stents 0, RFA 18) |
133 |
Lower GI endoscopy (Diagnostic 133, Tissue Resection 79, Stents 1) |
230 |
Enteroscopy |
16 |
Third Space Endoscopy |
6 |
Total Procedures |
751 |
Technical Success for procedures Failed outside ERCP 21; Failed outside EUS = 9; Failed outside resections = 6 |
99.2% |
Technical Failures: 7, failed cannulation = 3; failed resection = 2; failed EUS intervention = 2 |
0.8% |
Adverse Events: post-ERCP pancreatitis =4; post-resection bleeding =2 |
1.1% |
Referrals to Surgery/Others by CARE |
12 |
Inpatient Transfers to CARE |
137 |
Post-Procedure Admissions |
27 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery Gastro-jejunostomy Randomized Trial |
2 |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
423 |
Inpatient Procedures (Inclusive of outside transfers) |
116 |
ERCP |
97 |
EUS (Diagnostic 140, Biopsies 99, Stents 14, CP interventions 18) |
271 |
Upper GI endoscopy (Diagnostic 82, Tissue Resection 30, Stents 0, RFA 18) |
130 |
Lower GI endoscopy (Diagnostic 133, Tissue Resection 79, Stents 1) |
213 |
Enteroscopy |
19 |
Third Space Endoscopy |
12 |
Total Procedures |
742 |
Technical Success for procedures Failed outside ERCP 21; Failed outside EUS = 9; Failed outside resections = 6 |
99.1% |
Technical Failures: 7, failed cannulation = 3; failed resection = 2; failed EUS intervention = 2 |
0.9% |
Adverse Events: post-ERCP pancreatitis =4; post-resection bleeding =2 |
0.8% |
Referrals to Surgery/Others by CARE |
16 |
Inpatient Transfers to CARE |
121 |
Post-Procedure Admissions |
37 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
3 |
EUS vs. Surgery Gastro-jejunostomy Randomized Trial |
2 |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
353 |
Inpatient Procedures (Inclusive of outside transfers) |
208 |
ERCP |
95 |
EUS (Diagnostic 128, Biopsies 116, Stents 21, CP interventions 17) |
282 |
Upper GI endoscopy (Diagnostic 92, Tissue Resection 28, Stents 0, RFA 20) |
140 |
Lower GI endoscopy (Diagnostic 93, Tissue Resection 86 , Stents 0) |
179 |
Enteroscopy |
20 |
Third Space Endoscopy |
3 |
Total Procedures |
719 |
Clinical Outcomes |
|
Technical Success for procedures Failed outside ERCP = 17, Failed outside EUS = 11; Failed resections = 17 |
99.2% |
Technical Failures: 7, failed cannulation = 3; failed resection =3; failed EUS-guided interventions = 1 |
1.1% |
Adverse Events: post-ERCP pancreatitis =5 post-resection bleeding =1 |
0.79% |
Referrals to Surgery/Others by CARE |
12 |
Inpatient Transfers to CARE |
140 |
Post-Procedure Admissions |
29 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS vs. Surgery Gastrojejunostomy Randomized Trial |
2 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
462 |
Inpatient Procedures (Inclusive of outside transfers) |
211 |
ERCP |
109 |
EUS (Diagnostic 143, Biopsies 129, Stents 26, CP interventions 30) |
328 |
Upper GI endoscopy (Diagnostic 102, Tissue Resection 28, Stents 0, RFA 18) |
148 |
Lower GI endoscopy (Diagnostic 104, Tissue Resection 93 , Stents 0) |
197 |
Enteroscopy |
23 |
Third Space Endoscopy |
7 |
Total Procedures |
812 |
Clinical Outcomes |
|
Technical Success for procedures Failed outside ERCP = 21, Failed outside EUS = 19; Failed resections = 9 |
98.9% |
Technical Failures: 9, failed cannulation = 2; failed resection =2; failed EUS-guided interventions = 2, failed resection = 3 |
1.1% |
Adverse Events: post-ERCP pancreatitis =4; post-resection bleeding =2; post-FNA bleeding=2 |
0.98% |
Referrals to Surgery/Others by CARE |
12 |
Inpatient Transfers to CARE |
53 |
Post-Procedure Admissions |
32 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS - Pancreatic cancer molecular marker study |
2 |
Physician Journal Clubs |
1 |
Publications |
2 |
Outpatient Referrals |
354 |
Inpatient Procedures (Inclusive of outside transfers) |
129 |
ERCP |
89 |
EUS (Diagnostic 142, Biopsies 111, Stents 28, CP interventions 24) |
305 |
Upper GI endoscopy (Diagnostic 89, Tissue Resection 20, Stents 3, RFA 13) |
125 |
Lower GI endoscopy (Diagnostic 89, Tissue Resection 67, Stents 1) |
157 |
Enteroscopy |
20 |
Third Space Endoscopy |
2 |
Total Procedures |
698 |
Clinical Outcomes |
|
Technical Success for procedures Failed outside ERCP = 28, Failed outside EUS = 18 |
98.8% |
Technical Failures = 6, failed cannulation = 3; failed resection = 3 |
1.2% |
Adverse Events: Death 1 (aspiration); post-procedure pancreatitis 3; infection 1, bleeding 2 (post-resection) |
1.1% |
Referrals to Surgery/Others by CARE |
21 |
Inpatient Transfers to CARE |
136 |
Post-Procedure Admissions |
19 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
3 |
EUS vs. Surgery for Gastro-jejunostomy |
3 |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
341 |
Inpatient Procedures (Inclusive of outside transfers) |
129 |
ERCP |
93 |
EUS (Diagnostic 142, Biopsies 111, Stents 28, CP interventions 24) |
241 |
Upper GI endoscopy (Diagnostic 89, Tissue Resection 20, Stents 3, RFA 13) |
101 |
Lower GI endoscopy (Diagnostic 89, Tissue Resection 67, Stents 1) |
138 |
Enteroscopy |
24 |
Third Space Endoscopy |
6 |
Total Procedures |
603 |
Technical Success for procedures Failed outside ERCP = 28, Failed outside EUS = 18 |
98.5% |
Technical Failures = 6, failed cannulation = 3; failed resection = 3 |
1.5% |
Adverse Events: Death 1 (aspiration); post-procedure pancreatitis 3; infection 1, bleeding 2 (post-resection) |
1.1% |
Referrals to Surgery/Others by CARE |
6 |
Inpatient Transfers to CARE |
111 |
Post-Procedure Admissions |
22 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
2 |
EUS vs. Surgery for Gastro-jejunostomy |
COMPLETE |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
317 |
Inpatient Procedures (Inclusive of outside transfers) |
89 |
ERCP |
75 |
EUS (Diagnostic 141, Biopsies 98 , Stents 11, CP interventions 6 |
256 |
Upper GI endoscopy (Diagnostic 61, Tissue Resection 37 , Stents 1, RFA 4) |
103 |
Lower GI endoscopy (Diagnostic 49, Tissue Resection 86 , Stents 0) |
135 |
Enteroscopy |
8 |
Third Space Endoscopy |
14 |
Total Procedures |
591 |
Technical Success for procedures Failed outside ERCP = 13, Failed outside = 9, Failed polyp resections = 7 |
99.1% |
Technical Failures = 5, failed cannulation = 2 (altered anatomy), failed resection =2; failed EUS due to technical difficulty = 1 |
0.9% |
Adverse Events: Perforation 1 (altered anatomy), post-ERCP pancreatitis 3, post-procedure cholangitis 1 |
0.84% |
Referrals to Surgery/Others by CARE |
9 |
Inpatient Transfers to CARE |
138 |
Post-Procedure Admissions |
33 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
COMPLETE |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS - Pancreatic cancer molecular marker study |
COMPLETE |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
367 |
Inpatient Procedures (Inclusive of outside transfers) |
117 |
ERCP |
81 |
EUS (Diagnostic 124, Biopsies 109, Stents 13, CP interventions 5) |
251 |
Upper GI endoscopy (Diagnostic 76, Tissue Resection 47, Stents 0 , RFA 8 ) |
131 |
Lower GI endoscopy (Diagnostic 74, Tissue Resection 98) |
172 |
Enteroscopy |
16 |
Third Space Endoscopy |
4 |
Total Procedures |
655 |
Technical Success for procedures Failed outside ERCP = 13; Failed outside EUS = 12, Failed resection = 9 |
99.39% |
Technical Failures: 4 ; failed cannulation = 2 (altered anatomy); failed resection = 2 |
0.61% |
Adverse Events: Post-resection bleeding = 2, post-ERCP pancreatitis 4 |
0.91% |
Referrals to Surgery/Others by CARE |
6 |
Inpatient Transfers to CARE |
106 |
Post-Procedure Admissions |
28 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
2 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS - Pancreatic cancer molecular marker study |
0 |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
375 |
Inpatient Procedures (Inclusive of outside transfers) |
86 |
ERCP |
71 |
EUS (Diagnostic 128, Biopsies 81, Stents 14, CP interventions 15) |
238 |
Upper GI endoscopy (Diagnostic, 71 Tissue Resection 23, Stents 1, RFA 8) |
104 |
Lower GI endoscopy (Diagnostic 61, Tissue Resection 62) |
123 |
Enteroscopy |
11 |
Third Space Endoscopy |
4 |
Total Procedures |
551 |
Technical Success for procedures Failed outside ERCP = 11, Failed outside EUS = 5 |
99.6% |
Technical Failures = 2, failed cannulation = 1; failed resection =1 |
0.4% |
Adverse Events: Death 2 (unrelated to procedures); post-ERCP pancreatitis 2 |
0.36% |
Referrals to Surgery/Others by CARE |
7 |
Inpatient Transfers to CARE |
108 |
Post-Procedure Admissions |
12 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
2 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS - Pancreatic cancer molecular marker study |
COMPLETE |
Physician Journal Clubs |
1 |
Publications |
1 |
Outpatient Referrals |
301 |
Inpatient Procedures (Inclusive of outside transfers) |
71 |
ERCP |
79 |
EUS (Diagnostic 126, Biopsies 93, Stents 4, CP interventions 6) |
229 |
Upper GI endoscopy (Diagnostic 67, Tissue Resection 20, Stents 3, RFA 6) |
96 |
Lower GI endoscopy (Diagnostic 43, Tissue Resection 61, Stents 1) |
105 |
Enteroscopy |
12 |
Third Space Endoscopy |
7 |
Total Procedures |
528 |
Technical Success for procedures Failed outside ERCP =7; Failed outside EUS = 1; Failed outside resection = 9 |
98.8% |
Technical Failures: 6, failed resection = 5; failed cannulation = 1 |
1.1% |
Adverse Events: Post-ERCP cholangitis =1; post-ERCP pancreatitis = 2, Post-resection bleeding = 2 |
0.9% |
Referrals to Surgery/Others by CARE |
8 |
Inpatient Transfers to CARE |
62 |
Post-Procedure Admissions |
18 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
1 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS - Pancreatic cancer molecular marker study |
COMPLETED |
Physician Journal Clubs |
1 |
Publications |
0 |
Outpatient Referrals |
363 |
Inpatient Procedures (Inclusive of outside transfers) |
201 |
ERCP |
79 |
EUS (Diagnostic, Biopsies, Stents, CP interventions) |
231 |
Upper GI endoscopy (Diagnostic, Tissue Resection, Stents RFA) |
133 |
Lower GI endoscopy (Diagnostic, Tissue Resection, Stents) |
143 |
Enteroscopy |
9 |
Third Space Endoscopy |
6 |
Total Procedures |
601 |
Technical Success for procedures Failed outside ERCP = 10, Failed outside EUS = 9, Failed outside resection = 6 |
98.8% |
Technical Failures: 7, failed cannulation = 3, failed resection = 4 |
1.2% |
Adverse Events: Post-ERCP bile leak/death =1; Post-ERCP pancreatitis =4; Post-resection bleeding = 2 |
1.2% |
Referrals to Surgery/Others by CARE |
6 |
Inpatient Transfers to CARE |
110 |
Post-Procedure Admissions |
41 |
DESTIN (Pancreatic Necrosis Randomized Trial) |
1 |
BEEPER (Esophageal Neoplasia Randomized Trial) |
1 |
EUS - Pancreatic cancer molecular marker study |
COMPLETED |
Physician Journal Clubs |
1 |
Publications |
0 |
Outpatient Referrals | 317 |
Inpatient Procedures (Inclusive of outside transfers) | 198 |
ERCP | 64 |
EUS (Diagnostic 117, Biopsies 76, Stents 18, Tumor ablation/palliation 8) | 219 |
Upper GI endoscopy (Diagnostic 84, Tissue Resection 20, Stents 1, RFA 10) | 115 |
Lower GI endoscopy (Diagnostic 51, Tissue Resection 46, Stents 0) | 97 |
Enteroscopy | 16 |
Third Space Endoscopy | 4 |
Total Procedures | 515 |
Technical Success for procedures Failed outside ERCP = 12, Failed outside EUS = 6, Failed outside resection = 7 |
99% |
Technical Failures = 5 (failed cannulation =2, failed cannulation in altered anatomy = 1, failed resection =2) | 0.98% |
Adverse Events: Post-EUS bleeding =1; Post-ERCP pancreatitis = 2; post-necrosectomy free air = 2 | 0.98% |
Referrals to Surgery/Others by CARE | 9 |
Inpatient Transfers to CARE | 114 |
Post-Procedure Admissions | 25 |
DESTIN (Pancreatic Necrosis Randomized Trial) | 4 |
BEEPER (Esophageal Neoplasia Randomized Trial) | 1 |
EUS - Pancreatic cancer molecular marker study | 10 |
Physician Journal Clubs | 1 |
Publications | 0 |
Outpatient Referrals | 365 |
Inpatient Procedures (Inclusive of outside transfers) | 104 |
ERCP | 81 |
EUS (Diagnostic 98, Biopsies 87, Stents 12, CP interventions 6) | 203 |
Upper GI endoscopy (Diagnostic 72, Tissue Resection 18, Stents 2, RFA 9) | 101 |
Lower GI endoscopy (Diagnostic 42, Tissue Resection 68, Stents 0) | 110 |
Enteroscopy | 14 |
Third Space Endoscopy | 5 |
Total Procedures | 514 |
Technical Success for procedures Failed outside ERCP=14, Failed outside EUS=6, Failed resection=15 |
99.03% |
Technical Failures: 5 (Altered anatomy ERCP = 2; failed cannulation = 1; failed resection =2) | 0.97% |
Adverse Events: post-EUS bile leak=1; ERCP perforation=1; post-EMR bleeding =2; post-ERCP pancreatitis=2 | 1.19% |
Referrals to Surgery/Others by CARE | 2 |
Inpatient Transfers to CARE | 93 |
Post-Procedure Admissions | 28 |
DESTIN (Pancreatic Necrosis Randomized Trial) | 4 |
BEEPER (Esophageal Neoplasia Randomized Trial) | 2 |
EUS - Pancreatic cancer molecular marker study | 7 |
Physician Journal Clubs | 1 |
Publications | 1 |
Outpatient Referrals | 373 |
Inpatient Procedures (Inclusive of outside transfers) | 108 |
ERCP | 80 |
EUS (Diagnostic 110, Biopsies 102, Stents 16, CP interventions 3) | 231 |
Upper GI endoscopy (Diagnostic 80, Tissue Resection 14, Stents 1, RFA 5) | 100 |
Lower GI endoscopy (Diagnostic 14, Tissue Resection 59, Stents 0) | 73 |
Enteroscopy | 18 |
Third Space Endoscopy | 3 |
Total Procedures | 505 |
Technical Success for procedures Failed outside ERCP = 11; Failed outside resections = 13 |
99.61% |
Technical Failures: 2 (Altered anatomy ERCP = 2) | 0.39% |
Adverse Events: post-EUS drainage bleeding = 1; post EMR bleeding =1; post-ERCP; pancreatitis =2; post-ERCP cholangitis = 1 | 0.98% |
Referrals to Surgery/Others by CARE | 3 |
Inpatient Transfers to CARE | 83 |
Post-Procedure Admissions | 19 |
DESTIN (Pancreatic Necrosis Randomized Trial) | 2 |
BEEPER (Esophageal Neoplasia Randomized Trial) | 2 |
EUS - Pancreatic cancer molecular marker study | 4 |
Physician Journal Clubs | 1 |
Publications | 0 |
Outpatient Referrals | 344 |
Inpatient Procedures (Inclusive of outside transfers) | 72 |
ERCP | 66 |
EUS (Diagnostic 113, Biopsies 64, Stents 7, CP interventions 5) | 189 |
Upper GI endoscopy (Diagnostic 75, Tissue Resection 29, Stents 4, RFA 5) | 113 |
Lower GI endoscopy (Diagnostic 51, Tissue Resection 64, Stents 1) | 116 |
Enteroscopy | 18 |
Third Space Endoscopy | 7 |
Total Procedures | 509 |
Technical Success for procedures Failed outside ERCP = 21, Failed outside EUS = 11 |
99.3% |
Technical Failures: colon stent placement =1, failed gastric and colon ESD = 2; failed ERCP cannulation in altered anatomy = 1 | 0.7% |
Adverse Events: Post-FNA pancreatitis = 1, post colon EMR bleed = 1 | 0.38% |
Referrals to Surgery/Others by CARE | 3 |
Inpatient Transfers to CARE | 84 |
Post-Procedure Admissions | 17 |
DESTIN (Pancreatic Necrosis Randomized Trial) | 2 |
BEEPER (Esophageal Neoplasia Randomized Trial) | 1 |
EUS - Pancreatic cancer molecular marker study | 2 |
Physician Journal Clubs | 1 |
Publications | 1 |
Outpatient Referrals | 388 |
Inpatient Procedures (Inclusive of outside transfers) | 94 |
ERCP | 67 |
EUS (Diagnostic 138, Biopsies 69, Stents 16, CP interventions 5) | 228 |
Upper GI endoscopy (Diagnostic 60, Tissue Resection 19, Stents 4, RFA 3) | 86 |
Lower GI endoscopy (Diagnostic 72, Tissue Resection 27, Stents 0) | 99 |
Enteroscopy | 15 |
Third Space Endoscopy | 0 |
Total Procedures | 495 |
Technical Success for procedures Failed outside ERCP = 14; Failed outside EUS = 9 |
100% |
Technical Failures: 0 | - |
Adverse Events: 4 (perforation at double balloon ERCP =1; post-ERCP pancreatitis =2; post-glue injection bleeding =1) | 0.8% |
Referrals to Surgery/Others by CARE | 11 |
Inpatient Transfers to CARE | 21 |
Post-Procedure Admissions | 14 |
DESTIN (Pancreatic Necrosis Randomized Trial) | 5 |
BEEPER (Esophageal Neoplasia Randomized Trial) | 0 |
EUS - Pancreatic cancer molecular marker study | 0 |
Physician Journal Clubs | 1 |
Publications | 2 |
Outpatient Referrals | 292 |
Inpatient Procedures (Inclusive of outside transfers) | 58 |
ERCP | 65 |
EUS (Diagnostic 110, Biopsies 71, Stents 4, CP interventions 18) | 203 |
Upper GI endoscopy (Diagnostic 58, Tissue Resection 18, Stents 4, RFA 5) | 85 |
Lower GI endoscopy (Diagnostic 42, Tissue Resection 38) | 80 |
Enteroscopy | 6 |
Third Space Endoscopy | 8 |
Total Procedures | 447 |
Technical Success for procedures Failed outside ERCP=9, Failed outside EUS=6 |
99.6% |
Technical Failures: 2 (Failed cannulation at Double Balloon ERCP =1, colon tumor resection =1). | 0.41% |
Adverse Events: 2 (post-ERCP cholangitis=1, post-EMR bleeding=1). | 0.41% |
Referrals to Surgery by CARE | 13 |
Inpatient Transfers to CARE | 19 |
Post-Procedure Admissions | 20 |
DESTIN (Pancreatic Necrosis Randomized Trial) | 2 |
BEEPER (Esophageal Neoplasia Randomized Trial) | 1 |
EUS - Pancreatic cancer molecular marker study | 0 |
Physician Journal Clubs | 1 |
Publications | 0 |
Outpatient Referrals | 124 |
Inpatient Referrals | 129 |
Total Patient Visits | 253 |
Inpatient Transfers to CARE | 6 |
ERCP | 35 |
EUS | 114 |
Other Procedures (RFA, Enteroscopy, Stenting, Endoscopic Resections) | 101 |
POEM & Novel Procedures | 3 |
Total Procedures | 253 |
Referrals to Surgery/Others by CARE | 3 |
Post-Procedure Admissions | 13 |
DESTIN | 1 |
BEEPER | 0 |
Pancreatic cancer molecular marker study | 0 |
Physician Journal Clubs | 1 |
Publications | 2 |